Biotechnology News

Mon, 2013-12-09 19:02

WASHINGTON--(BUSINESS WIRE)--More than 60 advanced biofuel companies and 4 trade organizations asked leaders of the Congressional tax committees to extend biofuel tax credits.

Mon, 2013-12-09 19:02

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2014 first quarter results, Wednesday, December 11, 2013, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International...

Mon, 2013-12-09 19:02

RIDGEFIELD, Conn.--(BUSINESS WIRE)--Boehringer Ingelheim is proud to announce it has scored a perfect 100 in the Human Rights Campaign (HRC) Foundation’s Corporate Equality Index. The yearly report from the HRC ranks companies according to their...

Mon, 2013-12-09 14:08

NEW ORLEANS--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that more than 35 analyses from clinical studies of Jakafi® (ruxolitinib) were presented at the 2013 American Society of Hematology (ASH) Annual Meeting from Dec. 7...

Mon, 2013-12-09 14:08

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) announced today that the warrants issued in connection with the public offering in October 2013 are approved for trading in the United States on the OTC Bulletin Board under the...

Mon, 2013-12-09 14:08

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Global Blood Therapeutics Presents New Preclinical Data on Lead Sickle Cell Disease Drug Candidate, GTx011, at American Society of Hematology Annual Meeting

Mon, 2013-12-09 14:08

NEW ORLEANS--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today summarized ADCETRIS (brentuximab vedotin) data in Hodgkin lymphoma (HL) and non-Hodgkin lymphoma from multiple presentations at the 55th American Society of Hematology (ASH...

Mon, 2013-12-09 14:08

CAMBRIDGE, Mass. & STOCKHOLM--(BUSINESS WIRE)--New Phase 3 Data Confirm Long-Lasting Characteristics of ALPROLIX™ and ELOCTATE™ Across Multiple Hemophilia Populations

Mon, 2013-12-09 14:08

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate (ADC) technology, today announced the presentation of clinical findings with...

Mon, 2013-12-09 14:08

NEW ORLEANS--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced updated overall survival data from two ADCETRIS (brentuximab vedotin) pivotal Phase 2 clinical trials in...

Mon, 2013-12-09 14:08

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, announced that Dr. Jorge Cortes, deputy chair and professor of...

Mon, 2013-12-09 14:08

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Discovery IRAK4 Inhibitor Demonstrates Synergistic Effects in Preclinical Studies

Mon, 2013-12-09 14:08

CARY, N.C.--(BUSINESS WIRE)--Biologics Announces Collaborative Program Partnership for YERVOY® (ipilimumab) Patients - Biologics

Mon, 2013-12-09 14:08

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced it will host two life science workshops in California this month. The first, ‘Omics Approaches in Understanding Disease, will be held in San Diego on...

Mon, 2013-12-09 14:08

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron and Celgene report interim data from ongoing phase 2 trial of sotatercept at ASH -- dose dependent increase in hemoglobin in beta-thalassemia, rare anemia; FDA grants orphan drug status.

Mon, 2013-12-09 14:08

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will be presenting data demonstrating dramatic reductions in antibody development timelines by enabling large-scale transient...

Mon, 2013-12-09 14:08

BERLIN--(BUSINESS WIRE)--NOXXON Pharma disclosed interim data from two independent clinical phase IIa studies of the anti-CXCL12/SDF-1 Spiegelmer® olaptesed pegol (NOX-A12) in CLL and MM patients at 2013 ASH annual meeting.

Mon, 2013-12-09 14:08

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter has submitted an application to the U.S. FDA for a pediatric indication for RIXUBIS to treat hemophilia B, based on study results presented during the ASH Annual Meeting.

Mon, 2013-12-09 14:08

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories announces organizational changes to enhance global capabilities

Mon, 2013-12-09 14:08

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Presents Phase 3 Pooled Analysis of Once-Daily Aptiom® (eslicarbazepine acetate) as Adjunctive Treatment for Partial-Onset Seizures

Mon, 2013-12-09 14:08

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Presents Positive Results From Two Phase 3 Studies of Once-Daily Aptiom® (eslicarbazepine acetate) as Monotherapy Treatment for Partial-Onset Seizures

Mon, 2013-12-09 14:08

HERSHEY, Pa.--(BUSINESS WIRE)--New Era Orthopaedics LLC, an orthopaedic device manufacturer based in Pennsylvania, announced today that it has entered into an exclusive Distribution Agreement with French medical device manufacturer NeoSteo SAS...

Mon, 2013-12-09 14:08

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (Nasdaq:KMDA)(TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the appointment of Amir London to the newly-created position of Senior Vice...

Mon, 2013-12-09 14:08

--(BUSINESS WIRE)--Navy Director of Operational Energy to hold Q&A on advanced biofuel procurement opportunities with reporters and advanced biofuel companies at BIO Pacific Rim Summit conference in San Diego.

Mon, 2013-12-09 14:08

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the launch of a new oncology panel on its next generation sequencing (NGS) platform. The IntelliGEN assay improves sensitivity...

Mon, 2013-12-09 14:08

BASKING RIDGE, N.J.--(BUSINESS WIRE)--electroCore‘s non invasive VNS treatment for headache highlighted at recent AHS Annual Scottsdale Headache Symposium & 17th Annual NANS meeting

Mon, 2013-12-09 14:08

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience CEO Michelle Dipp, M.D., Ph.D., Joins Biotechnology Industry Organization’s Board of Directors

Mon, 2013-12-09 14:08

LEXINGTON, Mass.--(BUSINESS WIRE)--Alzheon has been invited to participate in the world's first G8 Dementia Summit, hosted by the British Prime Minister, David Cameron, and Health Secretary, Jeremy Hunt.

Mon, 2013-12-09 14:08

CAMBRIDGE, Mass.--(BUSINESS WIRE)--FoundationOne™ Heme Enables Identification of Genomic Alterations Not Identified By Conventional Methods Across Hematologic Malignancies

Mon, 2013-12-09 14:08

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted, antibody-based anticancer therapeutics, today announced the first clinical findings with SAR650984 reported in an oral presentation...

Mon, 2013-12-09 09:00

BOSTON & GENEVA--(BUSINESS WIRE)--The PHT Corporation NetPRO™ System is optimized and validated for clinical trial patients and clinicians on the Apple iPad. PHT technologies collect patient-driven eData for clinical research.

Mon, 2013-12-09 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Presents New Data Identifying Highly Selective, Oral Compounds and Novel Approach for the Treatment of Chronic Epilepsies

Mon, 2013-12-09 09:00

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (GMI) today announced that the company and its collaborators highlighted its novel glycomimetic drug candidate, E-selectin antagonist GMI-1271, during an oral presentation and poster session...

Mon, 2013-12-09 09:00

PRINCETON, N.J.--(BUSINESS WIRE)--ADVAXIS SIGNS EXCLUSIVE LICENSING AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF ADXS-HPV IN ASIA

Mon, 2013-12-09 09:00

TORONTO--(BUSINESS WIRE)--Ontario Bioscience Innovation Organization (“OBIO®”), a non-profit organization that is Ontario’s leading advocate for the life science sector, announces the election of three new members to its Board of Directors: Arun...

Mon, 2013-12-09 09:00

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) today announced positive results from both preclinical studies of the investigational product DX-2930 and its biomarker assay program for detection of contact system activation of...

Mon, 2013-12-09 09:00

ARDSLEY, N.Y.--(BUSINESS WIRE)--New data out of Ann'l Meeting of American Epilepsy Society: a study of Diazepam Nasal Spray found comparable PK whether the drug was administered during or immediately after a seizure.

Mon, 2013-12-09 09:00

WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta presented data from a pre-clinical study demonstrating that SEL-201 the ability to induce immune tolerance in a model of hemophilia A at the 2013 American Society for Hematology (ASH).

Mon, 2013-12-09 09:00

WATERTOWN, Mass.--(BUSINESS WIRE)--Selecta announced that the US Patent and Trademark Office has allowed the issuance of a Selecta-owned patent, first in a series of patent filings on antigen-specific tolerogenic immunotherapies.

Mon, 2013-12-09 09:00

HOLLYWOOD, Fla. & DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that data will be presented at the 52nd Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Hollywood, Fla., Dec. 8-12, 2013,...

Mon, 2013-12-09 09:00

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies reported results of cohort 3 in its Phase 1b/2a clinical study of SNS01-T at the 55th American Society of Hematology Annual Meeting in New Orleans.

Mon, 2013-12-09 09:00

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced positive interim results from a Phase 2 study evaluating the combination of otlertuzumab (TRU-016) and bendamustine versus bendamustine alone in people with...

Mon, 2013-12-09 09:00

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--True North Therapeutics presented data from preclinical efficacy studies of TNT009 for Cold Agglutinin Disease (CAD) at the 2013 American Society for Hematology (ASH) meeting in New Orleans.

Mon, 2013-12-09 09:00

SAN DIEGO--(BUSINESS WIRE)--KESA Partners is pleased to announce the formation of NuCollagen LLC, based in San Diego, CA. NuCollagen will manufacture laboratory and medical grade cGMP bovine collagen for the medical device, in-vitro diagnostic...

Mon, 2013-12-09 09:00

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR; NASDAQCM: MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that a hospital in the southeastern United...

Mon, 2013-12-09 09:00

GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Getinge Group has appointed Harald F. Stock as new President and Chief Executive Officer of ArjoHuntleigh, and Executive Vice President Extended Care Business Area. Harald will be a member of the...

Mon, 2013-12-09 09:00

LONDON--(BUSINESS WIRE)--Johnson & Johnson Innovation, London, today announces the formation of a network of partnering offices across UK life science clusters.

Mon, 2013-12-09 09:00

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that data from preclinical studies on its granulocyte colony stimulating factor (G-CSF) receptor agonist program were featured in a poster presentation today...

Mon, 2013-12-09 03:00

CHESHIRE, Conn.--(BUSINESS WIRE)--New Data Presented at ASH Annual Meeting Enhance Understanding of PNH and aHUS to Provide Optimal Care for Patients with These Life-threatening Disorders